| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 10.26 | -0.05 (-0.48%) | 9.12 - 33.31 | 402.0 thousand (Below Avg) |
Market data as of 3:59PM 05/16/12. Quotes are delayed by at least 15 min.
| Open | 10.39 |
|---|---|
| Previous Close | 10.31 |
| Day's Range | 10.23 - 10.55 |
| Market Cap | 309.1M |
| Avg Volume (10 Day) | 966.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -13.6 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Amedisys Reports First Quarter Financial Results and Reaffirms 2012 Guidance
Business Wire - Tuesday 05/08/2012 7:00 AM ET
Amedisys Receives Highest Recognition from the NHPCO We Honor Veterans Program
Business Wire - Monday 04/30/2012 7:00 AM ET
| AMED | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -6.86% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.26 | |
| LT Debt/Equity | 0.13 | |
| Earnings Yield | -- | |
| Price/Sales | 0.21 |
| Company | Last | Change |
|---|---|---|
| LHC Group Inc | 17.88 | -1.05% |
| Gentiva Health Services Inc | 6.86 | -3.65% |
| Almost Family Inc | 21.71 | -1.50% |
| Addus Homecare Corp | 4.00 | -4.53% |
| Chemed Corp | 57.70 | -0.77% |
Data is delayed by at least 15 min.